Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,563 recalls, newest first

Class II · Moderate risk

Antibacterial Hand Soap

CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.

Terminated cGMP deviation Inopak Ltd D-1315-2019
Class II · Moderate risk

INODERM Antiseptic Hand Soap

CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.

Terminated cGMP deviation Inopak Ltd D-1313-2019
Class II · Moderate risk

Losartan Potassium/HCTZ

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 0.96 parts per million.

Terminated Nitrosamine impurity RemedyRepack Inc. NDC 70518-1560-00 D-1270-2019
Class III · Low risk

Carvedilol Tablets

Presence of Foreign Tablets/Capsules: Customer complaint for a small, solid, light yellow substance, identified as a fragmented tablet of another drug product, found mixed with tablets in a bottle of Carvedilol tablets 3.125mg.

Terminated Particulate / foreign matter Zydus Pharmaceuticals USA Inc NDC 68382-092-05 D-1242-2019
Class I · High risk

FENTANYL Transdermal System

Product Mix-Up: Customer complaint that their carton labeled as Fentanyl Transdermal Systems, 12 mcg/h contained five patches labeled and containing 50 mcg/h.

Terminated Labeling / mix-up Alvogen, Inc NDC 47781-423-47 D-1277-2019

Recalls by year